Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease

Journal of Hepatology

Volumn 58, Issue 3, 2013, Pages 549-556

  Aravinthan, Aloysious ^a   Scarpini, Cinzia ^a   Tachtatzis, Phaedra ^a   Verma, Suman ^a   Penrhyn Lowe, Sue ^a   Harvey, Rebecca ^a   Davies, Susan E ^a   Allison, Michael ^a   Coleman, Nick ^a   Alexander, Graeme ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cell cycle arrest; Non alcohol related fatty liver disease; Senescence; Telomere

Indexed keywords

BIOLOGICAL MARKER; HISTONE H2AX; PROTEIN P21;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CELL AGING; CELL CYCLE ARREST; CELL CYCLE PHASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DNA DAMAGE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEATOSIS; TELOMERE HOMEOSTASIS;

ADULT; AGED; BIOPSY; CELL AGING; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HEPATOCYTES; HISTONES; HUMANS; MALE; MIDDLE AGED; TELOMERE;

EID: 84874115065     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.10.031     Document Type: Article

References (38)

1. N.M. de Alwis, and C.P. Day Non-alcoholic fatty liver disease: the mist gradually clears J Hepatol 48 2008 S104 112
2. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
3. M. Torbenson, S.Q. Yang, H.Z. Liu, J. Huang, W. Gage, and A.M. Diehl STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers Am J Pathol 161 2002 155 161
4. K.E. Behrns, G.G. Tsiotos, N.F. DeSouza, M.K. Krishna, J. Ludwig, and D.M. Nagorney Hepatic steatosis as a potential risk factor for major hepatic resection J Gastrointest Surg 2 1998 292 298
5. A.M. D'Alessandro, M. Kalayoglu, H.W. Sollinger, R.M. Hoffmann, A. Reed, and S.J. Knechtle The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation Transplantation 51 1991 157 163
6. S. Todo, A.J. Demetris, L. Makowka, L. Teperman, L. Podesta, and T. Shaver Primary nonfunction of hepatic allografts with preexisting fatty infiltration Transplantation 47 1989 903 905
7. V. Paradis, S. Zalinski, E. Chelbi, N. Guedj, F. Degos, and V. Vilgrain Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis Hepatology 49 2009 851 859
8. M. Collado, M.A. Blasco, and M. Serrano Cellular senescence in cancer and aging Cell 130 2007 223 233
9. S. Kawanishi, and S. Oikawa Mechanism of telomere shortening by oxidative stress Ann N Y Acad Sci 1019 2004 278 284
10. G. Saretzki, and T. Von Zglinicki Replicative aging, telomeres, and oxidative stress Ann N Y Acad Sci 959 2002 24 29
11. T. von Zglinicki Oxidative stress shortens telomeres Trends Biochem Sci 27 2002 339 344
12. T. von Zglinicki Role of oxidative stress in telomere length regulation and replicative senescence Ann N Y Acad Sci 908 2000 99 110
13. Y. Shiloh The ATM-mediated DNA-damage response: taking shape Trends Biochem Sci 31 2006 402 410
14. F. d'Adda di Fagagna Living on a break: cellular senescence as a DNA-damage response Nat Rev Cancer 8 2008 512 522
15. A. Celeste, S. Petersen, P.J. Romanienko, O. Fernandez-Capetillo, H.T. Chen, and O.A. Sedelnikova Genomic instability in mice lacking histone H2AX Science 296 2002 922 927
16. F. d'Adda di Fagagna, P.M. Reaper, L. Clay-Farrace, H. Fiegler, P. Carr, and T. Von Zglinicki A DNA damage checkpoint response in telomere-initiated senescence Nature 426 2003 194 198
17. I. Ben-Porath, and R.A. Weinberg The signals and pathways activating cellular senescence Int J Biochem Cell Biol 37 2005 961 976
18. J. Campisi, and F. D'Adda di Fagagna Cellular senescence: when bad things happen to good cells Nat Rev Mol Cell Biol 8 2007 729 740
19. E. Gonzalez-Reimers, M.M. Brajin-Rodriguez, N. Batista-Lopez, F. Santolaria-Fernandez, A. Martinez-Riera, and H. Essardas-Daryanani Hepatocyte and nuclear areas and fatty infiltration of the liver in chronic alcoholic liver disease Drug Alcohol Depend 22 1988 195 203
20. T. Nakajima, M. Moriguchi, T. Katagishi, S. Sekoguchi, T. Nishikawa, and H. Takashima Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD Liver Int 2 6 2006 23 31
21. T. Nakajima, T. Nakashima, Y. Okada, M. Jo, T. Nishikawa, and Y. Mitsumoto Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: comparison with telomere-specific quantitative FISH and p21 immunohistochemistry Pathol Int 60 2010 175 183
22. M.M. Richardson, J.R. Jonsson, E.E. Powell, E.M. Brunt, B.A. Neuschwander-Tetri, and P.S. Bhathal Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction Gastroenterology 133 2007 80 90
23. S. Verma, P. Tachtatzis, S. Penrhyn-Lowe, C. Scarpini, D. Jurk, and T. Von Zglinicki Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver Hepatology 2012
24. I. Ourliac-Garnier, and A. Londono-Vallejo Telomere length analysis by quantitative fluorescent in situ hybridization (Q-FISH) Methods Mol Biol 735 2011 21 31
25. S.U. Wiemann, A. Satyanarayana, M. Tsahuridu, H.L. Tillmann, L. Zender, and J. Klempnauer Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis FASEB J 16 2002 935 942
26. S. Oikawa, S. Tada-Oikawa, and S. Kawanishi Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening Biochemistry 40 2001 4763 4768
27. D. Bar-Or, G.W. Thomas, L.T. Rael, E.P. Lau, and J.V. Winkler Asp-Ala-His-Lys (DAHK) inhibits copper-induced oxidative DNA double strand breaks and telomere shortening Biochem Biophys Res Commun 282 2001 356 360
28. H. Malhi, and G.J. Gores Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease Semin Liver Dis 28 2008 360 369
29. S. Sakaguchi, S. Takahashi, T. Sasaki, T. Kumagai, and K. Nagata Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress Drug metabolism and pharmacokinetics 26 2011 30 46
30. M. Abdelmalek, J. Ludwig, and K.D. Lindor Two cases from the spectrum of nonalcoholic steatohepatitis J Clin Gastroenterol 20 1995 127 130
31. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and L.W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
32. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, and C.J. Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
33. F. Borel, F.B. Lacroix, and R.L. Margolis Prolonged arrest of mammalian cells at the G1/S boundary results in permanent S phase stasis J Cell Sci 115 2002 2829 2838
34. T. Watanabe, and Y. Tanaka Age-related alterations in the size of human hepatocytes. A study of mononuclear and binucleate cells Virchows Arch B Cell Pathol Incl Mol Pathol 39 1982 9 20
35. D.L. Schmucker Hepatocyte fine structure during maturation and senescence J Electron Microsc Tech 14 1990 106 125
36. S.Q. Gregg, V. Gutierrez, A. Rasile Robinson, T. Woodell, A. Nakao, and M.A. Ross A mouse model of accelerated liver aging caused by a defect in DNA repair Hepatology 55 2012 609 621
37. T. Serste, and N. Bourgeois Ageing and the liver Acta Gastroenterol Belg 69 2006 296 298
38. A.R. Choudhury, Z. Ju, M.W. Djojosubroto, A. Schienke, A. Lechel, and S. Schaetzlein Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation Nat Genet 39 2007 99 105